{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:21:55Z","timestamp":1783999315990,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.phrs.2010.08.001","type":"journal-article","created":{"date-parts":[[2010,8,7]],"date-time":"2010-08-07T08:47:37Z","timestamp":1281170857000},"page":"514-522","source":"Crossref","is-referenced-by-count":37,"title":["Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model"],"prefix":"10.1016","volume":"62","author":[{"given":"B\u00e1rbara","family":"Macedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rita","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jo\u00e3o","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2010.08.001_bib0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/bi00542a009","article-title":"Binding of thyroid hormones and analogues to the human plasma protein prealbumin","volume":"19","author":"Andrea","year":"1980","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2010.08.001_bib0010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1006\/jmbi.2002.5441","article-title":"Transthyretin fibrillogenesis entails the assembly of monomers, a molecular model for in vitro assembled transthyretin amyloid-like fibrils","volume":"317","author":"Cardoso","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.phrs.2010.08.001_bib0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1006\/bbrc.1996.5997","article-title":"Oxidative stress is found in amyloid deposits in systemic amyloidosis","volume":"232","author":"Ando","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.phrs.2010.08.001_bib0020","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1523\/JNEUROSCI.21-19-07576.2001","article-title":"Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways","volume":"21","author":"Sousa","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.phrs.2010.08.001_bib0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2119\/2007-00068.Macedo","article-title":"Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy","volume":"13","author":"Macedo","year":"2007","journal-title":"Mol Med"},{"key":"10.1016\/j.phrs.2010.08.001_bib0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2005.04.023","article-title":"Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview","volume":"827","author":"Mariani","year":"2005","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"10.1016\/j.phrs.2010.08.001_bib0035","doi-asserted-by":"crossref","first-page":"21998","DOI":"10.1074\/jbc.M602302200","article-title":"Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy","volume":"281","author":"Teixeira","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2010.08.001_bib0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-3565(25)10363-7","article-title":"Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger","volume":"263","author":"Yue","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2010.08.001_bib0045","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0022-3565(24)39002-0","article-title":"Effects of carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress","volume":"295","author":"Abreu","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2010.08.001_bib0050","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0006-2952(99)00417-7","article-title":"Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation","volume":"59","author":"Noguchi","year":"2000","journal-title":"Biochem Pharmacol"},{"issue":"Suppl. 11","key":"10.1016\/j.phrs.2010.08.001_bib0055","first-page":"41","article-title":"Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity","author":"Feuerstein","year":"1993","journal-title":"J Hypertens"},{"key":"10.1016\/j.phrs.2010.08.001_bib0060","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S0022-3565(25)09673-9","article-title":"Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low-density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells","volume":"273","author":"Yue","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2010.08.001_bib0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.bjp.0704717","article-title":"Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms","volume":"136","author":"Naidu","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2010.08.001_bib0070","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/bi0501030","article-title":"Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation","volume":"44","author":"Bieschke","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2010.08.001_bib0075","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0002-9440(10)64469-0","article-title":"Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro","volume":"161","author":"Sousa","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.phrs.2010.08.001_bib0080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF02820508","article-title":"Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis","volume":"6","author":"Almeida","year":"1997","journal-title":"Endocrine"},{"key":"10.1016\/j.phrs.2010.08.001_bib0085","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.phrs.2010.08.001_bib0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/BJ20040011","article-title":"Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative","volume":"381","author":"Almeida","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.phrs.2010.08.001_bib0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2010.08.001_bib0100","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/(SICI)1522-2683(19990601)20:7<1349::AID-ELPS1349>3.0.CO;2-5","article-title":"Electrically neutral microheterogeneity of human plasma transthyretin (prealbumin) detected by isoelectric focusing in urea gradients","volume":"20","author":"Altland","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.phrs.2010.08.001_bib0105","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/35037739","article-title":"Apoptosis in the nervous system","volume":"407","author":"Yuan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2010.08.001_bib0110","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1179\/016164103101202110","article-title":"Antioxidant properties of carvedilol: inhibition of lipid peroxidation, protein oxidation and superoxide generation","volume":"25","author":"SuzukiY","year":"2003","journal-title":"Neurol Res"},{"key":"10.1016\/j.phrs.2010.08.001_bib0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0014-5793(93)80446-2","article-title":"Generation of beta 4A from the amyloid protein precursor and fragments","volume":"335","author":"Dyrks","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1016\/j.phrs.2010.08.001_bib0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0006-8993(93)90918-D","article-title":"In vitro polymerization of oxidized tau into filaments","volume":"613","author":"Troncoso","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.phrs.2010.08.001_bib0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.phrs.2010.08.001_bib0130","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2010.08.001_bib0135","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1042\/bj3430419","article-title":"Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation","volume":"343","author":"Howlett","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.phrs.2010.08.001_bib0140","doi-asserted-by":"crossref","first-page":"44117","DOI":"10.1074\/jbc.M101958200","article-title":"Transient expression of wild-type or mitochondrially targeted Bcl-2 induces apoptosis, whereas transient expression of endoplasmic reticulum-targeted Bcl-2 is protective against Bax-induced cell death","volume":"276","author":"Wang","year":"2001","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.phrs.2010.08.001_bib0145","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbadis.2008.05.005","article-title":"Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of familial amyloidotic polyneuropathy","volume":"1782","author":"Macedo","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.phrs.2010.08.001_bib0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/00365510151067884","article-title":"Scavenger treatment of free radical injury in familial amyloidotic polyneuropathy: a study on Swedish transplanted and non-transplanted patients","volume":"61","author":"Suhr","year":"2001","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.phrs.2010.08.001_bib0155","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00795-005-0288-1","article-title":"Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP)","volume":"38","author":"Ando","year":"2005","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.phrs.2010.08.001_bib0160","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/13506120600876849","article-title":"Myocardial hypertrophy and function are related to age of onset in familial amyloidotic polyneuropathy","volume":"13","author":"Suhr","year":"2006","journal-title":"Amyloid"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661810001647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661810001647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T22:53:41Z","timestamp":1740351221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661810001647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1043661810001647"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2010.08.001","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}